EVO

NASDAQ · Equity

Evotec SE ADR

US Healthcare Drug Manufacturers - Specialty & Generic

Latest week
29 May 2026
Close
3.070000
Fair value
5.591294
Expectation
Negative 42.23%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
3.07
12-Week Change
32.90%
Trend Signal
Inactive
Expectation
Negative 42.23%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-27.83
Market Dynamics
-0.18

Over the latest 12 completed weeks ending 2026-05-29, EVO rose 32.90%, moving from 2.31 to 3.07. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -27.83 and has improved across the 12-week window. Market Dynamics is -0.18 on the latest week. Expectation is negative at 42.23%.